Key facts
- It has raised $49.3M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Shenzhen Capital Group, SAIC Capital China, Hillhouse Investment Group, Wuxi Capital Group, Wuxi Guolian Financial Investment Hehe Fund Management — 14 tracked in total.
- Status: Privately Held (backing).
Investors
14+- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Kai Medtech
- ·The full record, as it builds
Funding rounds
No funding rounds for Kai Medtech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kai Medtech
Manufacturer and supplier of medical devices designed to facilitate the treatment of cerebrovascular diseases. The company focuses on research and development of neurointerventional medical devices and provides integrated solutions, thereby enabling clients to receive better treatment for cerebrovascular and neurological disease.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Employees
- 96
- Website
- kaimtgroup.com/
- Ownership
- Privately Held (backing)
Kai Medtech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kai Medtech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kai Medtech in its N-PORT filings yet. We sweep new filings monthly.